Clinical Outcomes of Tanezumab With Different Dosages for Patient With Osteoarthritis: Network Meta-Analysis.

Hu, Rui; Song, Ya-Feng; Yang, Zhi-Yan; Zhang, Chao; Tan, Bo

Hu, Rui; Song, Ya-Feng; Yang, Zhi-Yan; Zhang, Chao; Tan, Bo.

Afiliação

Hu R; Department of Orthopedics, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Song YF; Department of Personnel Office, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Yang ZY; Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Zhang C; Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Tan B; Department of Orthopedics, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

Front Pharmacol ; 12: 614753, 2021.

Article em En | MEDLINE | ID: mdl-34177562

Palavras-chave

WOMAC; clinical outcomes; osteoarthritis; systematic review; tanezumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google